Yale New Haven Health is recognized as a national leader in transcatheter aortic valve replacement (TAVR) for patients with severe aortic stenosis (narrowing of the aortic heart valve).
Our Heart and Vascular Center is the first and only healthcare system in Connecticut to be certified by the American College of Cardiology for transcatheter valve replacement procedures. Certification is based on established national clinical measures to support clinical decisions and links process improvement to patient outcomes. Our integrated team specializes in treating the most complex cases and contributes to the field of transcatheter valve replacement through innovative research.
TAVR is a minimally invasive procedure that involves using a catheter from the leg or another approach to deliver a new aortic valve that replaces the heart’s diseased aortic valve without requiring open-heart surgery. It typically offers a shorter recovery time than traditional surgery. TAVR is a potential treatment for all patients with severe symptomatic aortic stenosis. Our valve team offers the Edwards SAPIEN 3™ valve and the Medtronic Evolut™ PRO valve.
Potential TAVR patients are evaluated by a multidisciplinary team of physicians that includes interventional cardiologists, cardiothoracic surgeons, echocardiographers and coordinators. This team approach results in a collaborative, personalized treatment plan.
If your doctor has told you that you have severe aortic stenosis, TAVR may be a viable treatment option. For more information or to schedule an appointment, call 203-785-7990.
During a TAVR procedure, an interventional cardiologist and a cardiothoracic surgeon work together in a cardiac catheterization laboratory or a special hybrid operating room with built-in imaging equipment. Typically, a small plastic tube is placed into the femoral artery in the patient's groin and moved through the patient's arterial system (the blood vessels that carry blood from the heart to the organs). It is delivered to replace the existing valve much like machine or even general anesthesia. Other arteries can be used if the femoral arteries are too small or blocked.
TAVR has many advantages over SAVR, especially in older or other high-risk patients. TAVR is much less invasive; avoids cardiopulmonary bypass and general anesthesia;, and involves a shorter hospital stay and faster recovery. Most of our TAVR procedures use femoral artery access, which allows next-day discharge in some cases and much quicker recovery after a procedure.
Aortic valve disease largely occurs with age. The same risk factors for coronary artery disease can predict aortic valve disease as well. One of the most common valve problems is caused by a congenital heart defect called bicuspid aortic valve, where the aortic valve can become blocked or leaky 20 to 30 years earlier than in healthy individuals.
A healthy lifestyle is the best way to avoid any heart disease — a good diet, exercise, avoiding tobacco use and paying careful attention to blood pressure and cholesterol. When risk factors for an abnormal heart valve are identified early, interventions and early treatment offer better outcomes.
Milford resident Nancy Earel underwent a transcatheter aortic valve replacement (TAVR) procedure that saved her life. The procedure involved replacing a faulty heart valve due to symptomatic severe aortic valve stenosis, a condition that can be fatal if left untreated
Read MoreYale New Haven Health is proud to be affiliated with the prestigious Yale University and its highly ranked Yale School of Medicine.